http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0267733-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 1987-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1989-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0267733-A3 |
| titleOfInvention | Cephalosporin compounds, process for their preparation and pharmaceutical compositions containing them |
| abstract | Cephalosporin compounds having a 3-position nsubstituent of the formula (I) are described: n-CH₂-Y-Q (I) nwherein Y is a linking group -NR⁴CO-Y′-, -NR⁴SO₂-Y′-, -OCO-Y;- nor -SCO-Y′- wherein R⁴ is hydrogen, various optionally nsubstituted alkyl groups or alkenyl and Y′ is a bond or various noptionally substituted alkylene or alkenylene groups; and nQ is a benzene ring (optionally fused to a further benzene nring so forming a naphthyl group or optionally fused to a 5 or n6 membered heterocyclic aromatic group containing 1, 2 or 3 nheteroatoms selected from nitrogen, oxygen and sulphur), said nbenzene ring (or in the case of naphthyl either benzene ring) nbeing substituted by groups R¹ and R² which are ortho with nrespect to one another, wherein R¹ is hydroxy or an in vivo nhydrolysable ester thereof and R² is hydroxy, an in vivo nhydrolysable ester thereof, carboxy, sulpho, hydroxymethyl, nmethanesulphonamido or ureido; or Q is a group of the formula n(II) or (III): n nwherein M is oxygen or a group NR³ nwherein R³ is hydrogen or C 1-4 alkyl; ring Q being further noptionally substituted. n The use of such compounds as antibacterial agents is ndescribed as are processes for their preparation and nintermediates therefor. |
| priorityDate | 1986-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.